OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Claudin-18.2 testing and its impact in the therapeutic management of patients with gastric and gastroesophageal adenocarcinomas: A literature review with expert opinion
Valentina Angerilli, Filippo Ghelardi, Floriana Nappo, et al.
Pathology - Research and Practice (2024) Vol. 254, pp. 155145-155145
Open Access | Times Cited: 6
Valentina Angerilli, Filippo Ghelardi, Floriana Nappo, et al.
Pathology - Research and Practice (2024) Vol. 254, pp. 155145-155145
Open Access | Times Cited: 6
Showing 6 citing articles:
Biomarkers in gastroesophageal cancer 2025: an updated consensus statement by the Spanish Society of Medical Oncology (SEOM) and the Spanish Society of Pathology (SEAP)
María Alsina, Ana Teijo‐Quintans, Míriam Cuatrecasas, et al.
Clinical & Translational Oncology (2025)
Open Access
María Alsina, Ana Teijo‐Quintans, Míriam Cuatrecasas, et al.
Clinical & Translational Oncology (2025)
Open Access
Extent and clinical significance of the therapy-relevant tight junction protein Claudin 18.2 in pancreatic ductal adenocarcinoma - real-world evidence
Su Ir Lyu, Caroline Fretter, Adrian Georg Simon, et al.
Translational Oncology (2024) Vol. 47, pp. 102044-102044
Open Access | Times Cited: 4
Su Ir Lyu, Caroline Fretter, Adrian Georg Simon, et al.
Translational Oncology (2024) Vol. 47, pp. 102044-102044
Open Access | Times Cited: 4
Construction of a Human Immune Library from Gallbladder Cancer Patients for the Single-Chain Fragment Variable (scFv) Antibody Selection against Claudin 18.2 via Phage Display
Brian Effer, Daniel Ulloa, Camila Dappolonnio, et al.
Antibodies (2024) Vol. 13, Iss. 1, pp. 20-20
Open Access | Times Cited: 2
Brian Effer, Daniel Ulloa, Camila Dappolonnio, et al.
Antibodies (2024) Vol. 13, Iss. 1, pp. 20-20
Open Access | Times Cited: 2
The preclinical discovery and development of zolbetuximab for the treatment of gastric cancer
Yongji Zeng, A. Craig Lockhart, Ramon U. Jin
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 8, pp. 873-886
Closed Access | Times Cited: 2
Yongji Zeng, A. Craig Lockhart, Ramon U. Jin
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 8, pp. 873-886
Closed Access | Times Cited: 2
Laparoscopic curative resection following perioperative chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin, and docetaxel and its influence on Claudin18.2 expression in advanced gastric or gastroesophageal junction adenocarcinoma: A two-case report
Tohru Takahashi, Takahiro Ishii, Taku Maejima, et al.
Research Square (Research Square) (2024)
Open Access
Tohru Takahashi, Takahiro Ishii, Taku Maejima, et al.
Research Square (Research Square) (2024)
Open Access
Evolving Treatment Landscape for Advanced Esophageal and Gastroesophageal Junction Adenocarcinoma
Margaret C. Wheless, M.B. Comer, Michael K. Gibson
Current Oncology Reports (2024) Vol. 26, Iss. 11, pp. 1469-1488
Open Access
Margaret C. Wheless, M.B. Comer, Michael K. Gibson
Current Oncology Reports (2024) Vol. 26, Iss. 11, pp. 1469-1488
Open Access
Discordance in Claudin 18.2 Expression Between Primary and Metastatic Lesions in Patients With Gastric Cancer
Seung-Myoung Son, Chang Gok Woo, Ok-Jun Lee, et al.
Journal of the Korean Gastric Cancer Association (2024) Vol. 25
Closed Access
Seung-Myoung Son, Chang Gok Woo, Ok-Jun Lee, et al.
Journal of the Korean Gastric Cancer Association (2024) Vol. 25
Closed Access
